White Paper
The digital revolution, aided by the growth in connectivity has provided drug developers access to a wealth of real-world, participant-generated data that is enabling better insights and streamlined clinical trial processes.
With this in mind, Validic conducted a survey of 166 biopharma and life sciences industry researchers, executives and technology/software professionals to provide insight into the benefits and challenges of using digital data and devices in clinical trials.